Screening for drugs to reduce aggression in zebrafish

被引:13
|
作者
Norton, William H. J. [1 ]
机构
[1] Univ Leicester, Coll Life Sci, Dept Neurosci Psychol & Behav, Leicester LE1 7RH, Leics, England
关键词
Zebrafish; Aggression; Drug screen; Neural circuit; Behaviour; BISPHENOL-A EXPOSURE; SOCIAL-BEHAVIOR; MODEL SYSTEM; DANIO-RERIO; MECHANISMS; FISH; IDENTIFICATION; ADOLESCENTS; BOLDNESS; CHILDREN;
D O I
10.1016/j.neuropharm.2018.10.023
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aggression is a common symptom of several human psychiatric disorders. However, the drugs available to treat aggression are non-specific and can have unwanted side effects. The zebrafish is an ideal model for behavioural pharmacology. They are small, aggression can be measured reliably, and drugs can be applied by immersion in the tank water. The ability to visualise and manipulate circuits in the intact brain represents an excellent opportunity to understand how chemical compounds modify the signalling pathways that control this behaviour. This review discusses protocols to measure zebrafish aggression, the neural circuits that control this behaviour and how pharmacological studies can inform us about environmental toxicology and the development of therapeutic drugs for humans. This article is part of the Special Issue entitled 'Current status of the neurobiology of aggression and impulsivity'.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Screening for drugs to reduce zebrafish aggression identifies caffeine and sildenafil
    Gutierrez, Hector Carremo
    Vacca, Irene
    Schoenmacker, Gido
    Cleal, Madeleine
    Tochwin, Anna
    O'Connor, Bethan
    Young, Andrew M. J.
    Vasquez, Alejandro Arias
    Winter, Matthew J.
    Parker, Matthew O.
    Norton, William H. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 30 : 17 - 29
  • [2] Screening for novel aggression therapeutics in zebrafish
    Norton, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 6 - 6
  • [3] Behavioral screening for neuroactive drugs in zebrafish
    Rihel, Jason
    Schier, Alexander F.
    DEVELOPMENTAL NEUROBIOLOGY, 2012, 72 (03) : 373 - 385
  • [4] Zebrafish Model for Screening Antiatherosclerosis Drugs
    Han, Jichun
    Zhang, Rui
    Zhang, Xiaofeng
    Dong, Jing
    Chen, Minghan
    Pan, Yumin
    Liao, Zixian
    Zhong, Min
    He, Jingwen
    Wang, Feiqiang
    Yue, Yunyun
    Shang, Jing
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2021, 2021
  • [5] Screening Zebrafish for Parkinson's disease drugs
    Le Bras, Alexandra
    LAB ANIMAL, 2021, 50 (11) : 310 - 310
  • [6] Screening Zebrafish for Parkinson’s disease drugs
    Alexandra Le Bras
    Lab Animal, 2021, 50 : 310 - 310
  • [8] Screening drugs for myocardial disease in vivo with zebrafish: an expert update
    Zhao, Yanbin
    Zhang, Kun
    Sips, Patrick
    MacRae, Calum A.
    EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (04) : 343 - 353
  • [9] A multilevel screening pipeline in zebrafish identifies therapeutic drugs for GAN
    Lescouzeres, Lea
    Hassen-Khodja, Cedric
    Baudot, Anais
    Bordignon, Benoit
    Bomont, Pascale
    EMBO MOLECULAR MEDICINE, 2023, 15 (07)
  • [10] DRUGS AND AGGRESSION
    PAUL, DM
    MEDICINE SCIENCE AND THE LAW, 1975, 15 (01) : 16 - 21